{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:32Z","timestamp":1789549352662,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10067-026-08355-w","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:36:58Z","timestamp":1787161018000},"page":"5979-5987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-centromere antibody positivity: a spectrum of clinical diagnoses and immunological patterns in a large patient cohort"],"prefix":"10.1007","volume":"45","author":[{"given":"Yadan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-6063","authenticated-orcid":false,"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-0406","authenticated-orcid":false,"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"4","key":"8355_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1083\/jcb.104.4.817","volume":"104","author":"WC Earnshaw","year":"1987","unstructured":"Earnshaw WC, Sullivan KF, Machlin PS et al (1987) Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol 104(4):817\u2013829. https:\/\/doi.org\/10.1083\/jcb.104.4.817","journal-title":"J Cell Biol"},{"key":"8355_CR2","doi-asserted-by":"publisher","first-page":"152606","DOI":"10.1016\/j.semarthrit.2024.152606","volume":"70","author":"M Binda","year":"2025","unstructured":"Binda M, Ortolan A, Moccaldi B et al (2025) Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: a systematic literature review and meta-analysis. Semin Arthritis Rheum 70:152606. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152606","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"8355_CR3","first-page":"1488","volume":"32","author":"S Miyawaki","year":"2005","unstructured":"Miyawaki S, Asanuma H, Nishiyama S et al (2005) Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 32(8):1488\u20131494","journal-title":"J Rheumatol"},{"issue":"7","key":"8355_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/1756-185X.12684","volume":"18","author":"KE Lee","year":"2015","unstructured":"Lee KE, Kang JH, Lee JW et al (2015) Anti-centromere antibody-positive Sjogren\u2019s syndrome: a distinct clinical subgroup? Int J Rheum Dis 18(7):776\u2013782. https:\/\/doi.org\/10.1111\/1756-185X.12684","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"8355_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s10067-024-06886-8","volume":"43","author":"M Hui","year":"2024","unstructured":"Hui M, Zhou J, Li M et al (2024) Digital gangrene in systemic sclerosis patients: not only due to the microvascular disease. Clin Rheumatol 43(3):1083\u20131092. https:\/\/doi.org\/10.1007\/s10067-024-06886-8","journal-title":"Clin Rheumatol"},{"issue":"9","key":"8355_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3899\/jrheum.2024-1063","volume":"52","author":"ER Volkmann","year":"2025","unstructured":"Volkmann ER, Assassi S, Denton CP et al (2025) Outcomes in systemic sclerosis-associated interstitial lung disease based on serological profiles with a focus on anticentromere and anti-RNA polymerase III antibodies. J Rheumatol 52(9):914\u2013918. https:\/\/doi.org\/10.3899\/jrheum.2024-1063","journal-title":"J Rheumatol"},{"key":"8355_CR7","doi-asserted-by":"publisher","first-page":"152667","DOI":"10.1016\/j.semarthrit.2025.152667","volume":"72","author":"EM Hoekstra","year":"2025","unstructured":"Hoekstra EM, Liem SIE, Boonstra M et al (2025) The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature. Semin Arthritis Rheum 72:152667. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152667","journal-title":"Semin Arthritis Rheum"},{"key":"8355_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003148","author":"CM Wortel","year":"2023","unstructured":"Wortel CM, Liem SI, van Leeuwen NM et al (2023) Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003148","journal-title":"RMD Open"},{"issue":"6","key":"8355_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","volume":"37","author":"R Liberal","year":"2013","unstructured":"Liberal R, Grant CR, Sakkas L et al (2013) Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 37(6):572\u2013585. https:\/\/doi.org\/10.1016\/j.clinre.2013.04.005","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"8355_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10157-012-0724-1","volume":"17","author":"S Mandai","year":"2013","unstructured":"Mandai S, Kanda E, Arai Y et al (2013) Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis. Clin Exp Nephrol 17(3):405\u2013410. https:\/\/doi.org\/10.1007\/s10157-012-0724-1","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"8355_CR11","doi-asserted-by":"publisher","first-page":"e0322845","DOI":"10.1371\/journal.pone.0322845","volume":"20","author":"S Zou","year":"2025","unstructured":"Zou S, Zhang R, Yang D et al (2025) Clinical manifestations and immune correlations in anti-centromere antibody-positive and anti-SSA\/Ro antibody-positive primary Sjogren\u2019s syndrome: a retrospective analysis. PLoS ONE 20(8):e0322845. https:\/\/doi.org\/10.1371\/journal.pone.0322845","journal-title":"PLoS ONE"},{"issue":"1","key":"8355_CR12","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1038\/s41598-024-55767-2","volume":"14","author":"T Shimizu","year":"2024","unstructured":"Shimizu T, Nishihata SY, Nakamura H et al (2024) Anti-centromere antibody positivity is an independent variable associated with salivary gland ultrasonography score in Sjogren\u2019s syndrome. Sci Rep 14(1):5303. https:\/\/doi.org\/10.1038\/s41598-024-55767-2","journal-title":"Sci Rep"},{"issue":"3","key":"8355_CR13","first-page":"145","volume":"36","author":"C Notarstefano","year":"2018","unstructured":"Notarstefano C, Croia C, Pontarini E et al (2018) A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 36(3):145\u2013149","journal-title":"Clin Exp Rheumatol"},{"key":"8355_CR14","doi-asserted-by":"publisher","first-page":"1762899","DOI":"10.3389\/fimmu.2026.1762899","volume":"17","author":"X Liu","year":"2026","unstructured":"Liu X, Xiao Z, Yao Y et al (2026) Anti-CENP-B polarity divides SLE: divergent clinical-immune phenotypes and distinct treatment responses. Front Immunol 17:1762899. https:\/\/doi.org\/10.3389\/fimmu.2026.1762899","journal-title":"Front Immunol"},{"issue":"1","key":"8355_CR15","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1038\/s41598-017-07137-4","volume":"7","author":"N Kuramoto","year":"2017","unstructured":"Kuramoto N, Ohmura K, Ikari K et al (2017) Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Sci Rep 7(1):6911. https:\/\/doi.org\/10.1038\/s41598-017-07137-4","journal-title":"Sci Rep"},{"issue":"2","key":"8355_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cld.2008.02.009","volume":"12","author":"L Muratori","year":"2008","unstructured":"Muratori L, Granito A, Muratori P et al (2008) Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis 12(2):261\u201376. https:\/\/doi.org\/10.1016\/j.cld.2008.02.009","journal-title":"Clin Liver Dis"},{"issue":"12","key":"8355_CR17","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.41814","volume":"73","author":"NM van Leeuwen","year":"2021","unstructured":"van Leeuwen NM, Boonstra M, Bakker JA et al (2021) Anticentromere antibody levels and isotypes and the development of systemic sclerosis. Arthritis Rheumatol 73(12):2338\u20132347. https:\/\/doi.org\/10.1002\/art.41814","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"8355_CR18","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3748\/wjg.v20.i10.2606","volume":"20","author":"S Yamagiwa","year":"2014","unstructured":"Yamagiwa S, Kamimura H, Takamura M et al (2014) Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol 20(10):2606\u20132612. https:\/\/doi.org\/10.3748\/wjg.v20.i10.2606","journal-title":"World J Gastroenterol"},{"key":"8355_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","volume":"6","author":"EK Chan","year":"2014","unstructured":"Chan EK, Damoiseaux J, Carballo OG et al (2014) Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015. Front Immunol 6:412. https:\/\/doi.org\/10.3389\/fimmu.2015.00412","journal-title":"Front Immunol"},{"issue":"1","key":"8355_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","volume":"6","author":"M Mosca","year":"2006","unstructured":"Mosca M, Tani C, Neri C et al (2006) Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 6(1):1\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2006.03.004","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8355_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","volume":"18","author":"S Sciascia","year":"2022","unstructured":"Sciascia S, Roccatello D, Radin M et al (2022) Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. Nat Rev Rheumatol 18(1):9\u201321. https:\/\/doi.org\/10.1038\/s41584-021-00710-2","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8355_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.autrev.2015.10.001","volume":"15","author":"F Perosa","year":"2016","unstructured":"Perosa F, Prete M, Di Lernia G et al (2016) Anti-centromere protein A antibodies in systemic sclerosis: significance and origin. Autoimmun Rev 15(1):102\u2013109. https:\/\/doi.org\/10.1016\/j.autrev.2015.10.001","journal-title":"Autoimmun Rev"},{"issue":"4 Pt 1","key":"8355_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0190-9622(86)70217-x","volume":"15","author":"A Ruffatti","year":"1986","unstructured":"Ruffatti A, Peserico A, Glorioso S et al (1986) Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 15(4 Pt 1):637\u2013642. https:\/\/doi.org\/10.1016\/s0190-9622(86)70217-x","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"8355_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/s0025-6196(12)62059-x","volume":"59","author":"FC Powell","year":"1984","unstructured":"Powell FC, Winkelmann RK, Venencie-Lemarchand F et al (1984) The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc 59(10):700\u2013706. https:\/\/doi.org\/10.1016\/s0025-6196(12)62059-x","journal-title":"Mayo Clin Proc"},{"key":"8355_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125734","author":"Y Park","year":"2025","unstructured":"Park Y, Lee JJ, Ju JH et al (2025) Clinical characterization of autoimmune hepatic involvement in Sjogren\u2019s disease: a retrospective cohort study in Korea. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26125734","journal-title":"Int J Mol Sci"},{"issue":"11","key":"8355_CR26","doi-asserted-by":"publisher","first-page":"e0259519","DOI":"10.1371\/journal.pone.0259519","volume":"16","author":"HK Min","year":"2021","unstructured":"Min HK, Kim SH, Park Y et al (2021) Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjogren\u2019s syndrome. PLoS ONE 16(11):e0259519. https:\/\/doi.org\/10.1371\/journal.pone.0259519","journal-title":"PLoS ONE"},{"issue":"1","key":"8355_CR27","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1038\/s41467-025-63935-9","volume":"16","author":"J Inamo","year":"2025","unstructured":"Inamo J, Takeshita M, Suzuki K et al (2025) Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjogren\u2019s disease reveals common and distinct immune activation and fibroblast-mediated inflammation. Nat Commun 16(1):8299. https:\/\/doi.org\/10.1038\/s41467-025-63935-9","journal-title":"Nat Commun"},{"issue":"12","key":"8355_CR28","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1002\/art.38867","volume":"66","author":"C Terao","year":"2014","unstructured":"Terao C, Ohmura K, Yamada R et al (2014) Association between antinuclear antibodies and the HLA class II locus and heterogeneous characteristics of staining patterns: the Nagahama study. Arthritis Rheumatol 66(12):3395\u20133403. https:\/\/doi.org\/10.1002\/art.38867","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"8355_CR29","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/ar3029","volume":"12","author":"M Mahler","year":"2010","unstructured":"Mahler M, Maes L, Blockmans D et al (2010) Clinical and serological evaluation of a novel CENP-A peptide based ELISA. Arthritis Res Ther 12(3):R99. https:\/\/doi.org\/10.1186\/ar3029","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8355_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.dld.2024.12.024","volume":"57","author":"D Ding","year":"2025","unstructured":"Ding D, Jia G, Cui L et al (2025) The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: enhancing the prognostic utility on the GLOBE scoring system. Dig Liver Dis 57(4):861\u2013868. https:\/\/doi.org\/10.1016\/j.dld.2024.12.024","journal-title":"Dig Liver Dis"},{"issue":"2","key":"8355_CR31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40744-018-0126-2","volume":"5","author":"M Tsukamoto","year":"2018","unstructured":"Tsukamoto M, Suzuki K, Takeuchi T (2018) Clinical and immunological features of anti-centromere antibody-positive primary Sjogren\u2019s syndrome. Rheumatol Ther 5(2):499\u2013505. https:\/\/doi.org\/10.1007\/s40744-018-0126-2","journal-title":"Rheumatol Ther"},{"issue":"5","key":"8355_CR32","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s10067-026-08014-0","volume":"45","author":"ZA Akar","year":"2026","unstructured":"Akar ZA, Yildirim D (2026) Prevalence, clinical features, and laboratory predictors of autoimmune hepatitis in systemic sclerosis: a retrospective single-center cohort study. Clin Rheumatol 45(5):2749\u20132757. https:\/\/doi.org\/10.1007\/s10067-026-08014-0","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8355_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/1756-185X.13439","volume":"22","author":"M Tsukamoto","year":"2019","unstructured":"Tsukamoto M, Suzuki K, Takeuchi T (2019) Initial presentation determines clinical entity in patients with anti-centromere antibody positivity. Int J Rheum Dis 22(1):103\u2013107. https:\/\/doi.org\/10.1111\/1756-185X.13439","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"8355_CR34","doi-asserted-by":"publisher","first-page":"11212","DOI":"10.1038\/s41598-022-15062-4","volume":"12","author":"KEN Clark","year":"2022","unstructured":"Clark KEN, Campochiaro C, Host LV et al (2022) Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes. Sci Rep 12(1):11212. https:\/\/doi.org\/10.1038\/s41598-022-15062-4","journal-title":"Sci Rep"},{"issue":"4","key":"8355_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/03009740600588376","volume":"35","author":"N Respaldiza","year":"2006","unstructured":"Respaldiza N, Wichmann I, Ocana C et al (2006) Anti-centromere antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 35(4):290\u2013294. https:\/\/doi.org\/10.1080\/03009740600588376","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 3","key":"8355_CR36","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.5152\/eurjrheum.2020.19114","volume":"7","author":"ZR Brown","year":"2020","unstructured":"Brown ZR, Nikpour M (2020) Screening for pulmonary arterial hypertension in systemic sclerosis: now or never! Eur J Rheumatol 7(Suppl 3):S187\u2013S192. https:\/\/doi.org\/10.5152\/eurjrheum.2020.19114","journal-title":"Eur J Rheumatol"},{"issue":"8","key":"8355_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/00365513.2025.2598748","volume":"85","author":"Y Jin","year":"2025","unstructured":"Jin Y, Wu J, Liu S et al (2025) Quantitative detection of anti-centromere antibodies in primary biliary cholangitis: value of chemiluminescence immunoassay. Scand J Clin Lab Invest 85(8):675\u2013681. https:\/\/doi.org\/10.1080\/00365513.2025.2598748","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08355-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08355-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:21Z","timestamp":1789545861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08355-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8355"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08355-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted following the ethical principles of the Declaration of Helsinki and was approved by the Ethics Committee of Xijing Hospital (No. KY20212107). Patient consent was waived due to retrospective character of the study.","order":1,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures\u00a0","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}